Turkmenistan vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB

Turkmenistan
100.0%
in 2022
Western Pacific (WHO region)
86.0%
in 2024
Turkmenistan rank
1st
Western Pacific (WHO region) rank
3rd

Previously treated cases tested for RR-/MDR-TB over time

  • Turkmenistan
  • Western Pacific (WHO region)
020406080100200520142024

How they compare

Turkmenistan currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.

That makes Turkmenistan's figure about 1.2 times Western Pacific (WHO region)'s.

The two have swapped places 2 times across 6 shared years of data; in 2006 it was Turkmenistan ahead.

Turkmenistan ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.

Turkmenistan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Turkmenistan Western Pacific (WHO region) Difference Ahead
2000s 42.0% 0.6% 41.4% Turkmenistan
2010s 55.0% 33.2% 21.8% Turkmenistan
2020s 100.0% 88.7% 11.3% Turkmenistan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Turkmenistan or Western Pacific (WHO region)?
Turkmenistan, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2022.
What is the difference in previously treated cases tested for rr-/mdr-tb between Turkmenistan and Western Pacific (WHO region)?
14.0%, with Turkmenistan ahead.
How many years of comparable data are there for Turkmenistan and Western Pacific (WHO region)?
6 years are reported by both, from 2006 to 2022.
How do Turkmenistan and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
Turkmenistan ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Turkmenistan vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/turkmenistan/western-pacific-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/turkmenistan/western-pacific-who-region/">Turkmenistan vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed